Moderna IncVaccine met primary goals in Phase 3 testing
The U.S. Treasury announced plans to double liquidity support buyback operations on longer-end securities, sending bond yields notably lower and lifting market indexes ahead of the open. The current buyback position of $2 billion per operation will now become $4 billion, with the 30-year bond dropping below 5.3%, the 10-year beneath 4.7%, and the 2-year under 4.2%. Moderna shares surged 95% after its intismeran vaccine met primary goals in Phase 3 testing for preventing cancer in melanoma patients, while partner Merck rose 7%. Target reported beats on both top and bottom lines with earnings of $2.46 per share on revenues of $26.54 billion, but shares fell 1% despite raised guidance. Lowe's posted mixed results with earnings of $4.40 per share beating estimates while revenues of $25.96 billion missed, and TJX Companies outperformed with earnings of $1.22 per share but fell 3.3% on a weaker outlook. Estee Lauder shares jumped 12% after fiscal Q4 earnings of $0.39 per share beat the $0.32 anticipated on revenues of $3.63 billion.
Moderna IncVaccine met primary goals in Phase 3 testing
Merck & Company IncPartner's vaccine met primary goals in Phase 3
Estee Lauder Companies IncFiscal Q4 earnings beat estimates
Target CorporationShares fell despite beats and raised guidance
Lowe's Companies IncRevenues missed estimates
The TJX Companies IncTJX reported earnings beat but fell 3.3% on a weaker outlook.
Merck KGaA